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Abstract Purpose: To evaluate
whether an in-line filter inserted in
the syringe pump infusion line
assembly influences start-up times
and flow irregularities during vertical
pump displacement at low infusion
rates. Methods: Fluid delivery after
syringe pump start-up and after ver-
tical displacement of the syringe
pump by -50 cm was determined
gravimetrically at flow rates of 0.5,
1.0 and 2.0 ml h-1. Measurements
were repeated for each flow rate four
times with two different syringe
pumps with and without an in-line
filter incorporated. Data are shown as
median and range. Results: Start-up
times were reduced by an in-line filter
at 0.5 ml h-1 flow rate from 355.5 s
(0–660) to 115 s (0–320), whereas the
effect was attenuated at higher flow
rates. Pooling of fluid into the infu-
sion system after lowering the
infusion syringe pump was halved in
all flow rates tested. Amount of
infusion bolus after elevating the
syringe pump by 50 cm was not
affected by an in-line filter.
Conclusion: In the evaluated model
in-line filters help to reduce flow
irregularities and delay in drug
delivery of syringe pumps at low flow
rates and represent an option to opti-
mize continuous administration of
highly concentrated short-acting
drugs at very small infusion rates.
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Introduction
Prompt infusion start-up and continuous delivery of
highly concentrated short-acting drugs at low infusion
rates from pressure-controlled infusion pumps are ham-
pered by intrinsic compliance. Syringe pump gaps and
syringe and infusion line compliance facilitate fluid
pooling into or fluid emptying from the system during
vertical pump displacement and result in start-up delays
[1–11].
In-line filters in an infusion line assembly represent a
resistance element necessitating a higher driving pressure.
We hypothesize that insertion of an in-line filter between
infusion syringe and infusion line increases intra-syringe
pressure shifting the volume pressure curve to a less
compliant range. A reduced compliance helps to improve
start-up times as well as stabilise steady state flow char-
acteristics during vertical pump displacement. Thus, the
aim of this study was to evaluate whether an in-line filter
inserted in the syringe pump infusion line assembly
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influences start-up times and flow irregularities during
vertical pump displacement at low infusion rates.
Methods
Experimental set-up
In an in vitro set-up, start-up times and steady state per-
formance during hydrostatic pressure changes were
evaluated using a standard syringe infusion pump with
and without an in-line filter.
An Alaris Asena GH syringe pump (IVAC Medical
Systems, Hampshire, UK) was used with 50-ml Fresenius
infusion syringes (Fresenius AG, Bad Homburg,
Germany). A neonatal Pall in-line filter device (Pall
Posidyne Neo Filter 0.2 lm, Pall AG Switzerland,
Basel, Switzerland) coupled with a stopcock was included
between one 200-cm and one 10-cm non-compliant
infusion line (PE-Infusion Line, Acromed AG, Regensdorf,
Switzerland) which was connected to a 22-Gauge 10-cm
central venous line (Teleflex Medical GmbH, Belp,
Switzerland) (Fig. 1).
For each experiment, the syringe was filled with 0.9%
normal saline and inserted into the syringe pump. An
automated priming procedure (extrusion of a 0.5-ml fluid
bolus) was performed prior to start in order to overcome
any mechanical gaps within the system.
For all experiments with and without an in-line filter,
the tip of distal end of the central venous line was
immersed by 7 cm in a sampling glass filled with distilled
water. In order to simulate a central venous pressure of
7 mmHg, the pump outlet was positioned at the level of
the immersed central venous line tip. A thin layer of oil
covered the water surface to avoid any fluid evaporation.
Assuming a specific weight of 0.9% normal saline of
1 g ml-1 at room temperature, fluid delivery (ml h-1)
into the sampling beaker was gravimetrically determined
using an electronic balance (AG 204-Delta-Range,
Mettler Toledo, Schwerzenbach, Switzerland; sensitivity
0.0001 g). The balance data output was recorded in 10-s
intervals by an IBM-compatible personal computer
employing software specifically written for this purpose
(MCPS V2.6-CAD, Software GmbH, Mo¨nchengladbach,
Germany).
Experiments performed
Start-up and steady state performance
The pumps were started at an infusion rate of 0.5 ml h-1.
Elapsed time from depressing the start button to first fluid
delivery as indicated by the electronic balance
(TTFFD = time to first fluid delivery) and time until
achieving 95% of steady state flow (TTSSF95 = time to
95% steady state flow) were recorded.
Vertical pump displacements
At steady state flow conditions, the pumps were lowered
by 50 cm and the resulting retrograde aspiration volume
(RAV, amount of fluid backflow into the syringe infusion
line assembly), zero drug delivery time (ZDDT) and no
flow time (NFT, backflow time and steady state until
forward flow appears) were assessed. Since the pump-
lowering manoeuvre is followed by an immediate weight
drop on the balance due to fluid backflow from the beaker
towards the tubing, ZDDT was defined as the time
interval between pump lowering and re-attainment of the
beaker weight that was measured immediately before
vertical pump displacement. After steady state flow
delivery was re-established, the pump was elevated to its
original vertical position.
At steady state flow conditions, the pumps were ele-
vated by 50 cm, resulting in the release of an infusion
bolus (IB) and an overshooting flow rate as a result from
the immediate hydrostatic pressure relief.
Each experiment was performed four times using two
syringe pumps with and without an in-line filter at flow
Syringe pump infusion line (200cm)
stop
cock
in-line
filter
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line
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Fig. 1 Study design for in vitro
measurements
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rates of 0.5, 1.0, 2.0 ml h-1 (total = 4 9 2 9 2 9
3 = 48 measurements). All experiments were done in a
randomized order at 22–24C ambient temperature.
Data were compared using Mann–Whitney U test.
Data are presented as median and range because of
abnormal distribution. A p value of less than 0.05 was
considered statistically significant. Data analysis was
performed using Microsoft Office Excel 2003, SPSS
Statistics 17.0 and IDL 7.1 (ITT Visual Information
Solutions).
Results
Measured or calculated parameters are summarized in
Table 1. Comparing all three different flow rates the
highest TTFFD is measured at 0.5 ml h-1 with and
without an in-line filter. TTFFD was not significantly
influenced by an in-line filter at all flow rates, although
it is more than halved by an in-line filter at 0.5 ml h-1.
However, TTSSF95 was reduced significantly by an in-
line filter at 0.5 and 2.0 ml h-1, whereas the effect was
not shown at 1.0 ml h-1 flow rate. In summary, start-up
delay is not augmented by an in-line filter.
Fluid pooling into the infusion system, as indicated
by NFT, ZDDT and RAB, was reduced by half with an
in-line filter during lowering the syringe pump by
50 cm at all flow rates. Amount of infusion bolus after
elevating the syringe pump by 50 cm was not affected
by the inclusion of an in-line filter. Figure 2 shows the
results obtained at 0.5 and 2.0 ml h-1 flow rates.
Discussion
The aim of this pilot study was to evaluate whether an
in-line filter inserted in the syringe pump infusion line
assembly influences start-up times and flow irregulari-
ties during vertical pump displacement at low infusion
rates in the evaluated model.
The main findings of the study were that TTFFD
was halved by the in-line filter at an infusion rate of
0.5 ml h-1 and TTSSF95 was significantly shorter with
an in-line filter at an infusion rate of 0.5 and 2.0 ml h-1,
whereas this effect could not be shown at 1.0 ml h-1
flow rate. Similarly, fluid pooling into the infusion
system was reduced by half with an in-line filter
included in the infusion line assembly during lowering
the syringe pump by 50 cm. Although some data are not
statistically significant, all data show a tendency to
reduced flow irregularities. In neonatal and paediatric
intensive care highly concentrated short-acting drugs
like catecholamines often run on low infusion rates.
According to the data obtained in this study, the T
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reduction of flow irregularities by in-line filters may lead
to a stabilization of circulation and blood pressure during
syringe/line change and on transport. Further investiga-
tions are necessary to prove these potential benefits.
Flow irregularities are mainly caused by compliance
of the infusion line, the syringe and the pump. In the past
several attempts to reduce compliance and to overcome
these shortcomings of infusion syringe pumps were per-
formed. The FASTSTART procedure seems to be
effective and substantial improvements can be obtained
by priming the system prior to starting [4]. Syringe
design, syringe pump design and different tested pumps
led to clinically relevant flow irregularities during vertical
displacement [5–7]. Smaller syringes, two-piece syringes
and infusion rates greater than 1 ml h-1 are recom-
mended when highly concentrated drugs are administered
[6, 9, 10], but often flow rates less than 1 ml h-1 are
necessary in neonatal and paediatric patients.
The costs of these in-line filters must be calculated as
most of the children need several drug infusions with
integrated in-line filters and these in-line filters have to be
replaced every 72–96 h. But this low-cost device seems to
have other positive effects in addition to those mentioned
above. In-line filters interposed in intravenous infusion
systems may prevent the accidental administration of
particles, precipitated drugs, microorganisms, endotoxins
and air [12, 13]. A number of studies have demonstrated
that if integrated into a package of measures, the costs of
in-line filters can be offset against other savings [14, 15].
A few limitations of this study must be acknowledged.
Real patient features (e.g. undulating venous pressure,
presence of other infusion pumps delivering through the
same catheter lumen) may introduce additional factors
that alter the observed effects. Not all of our results are
statistically significant most likely because of the small
number of experiments. In our study we did not analyse
the influence of material, length, diameter of the lines and
resistance of the in-line filters. Some of these aspects were
investigated in previous studies [6, 8, 9]. Our findings
have to be confirmed by other studies including different
set-up, materials and higher flow rates.
On the basis of our study findings in-line filters help to
reduce flow irregularities and delay in drug delivery and
may represent a further step in reducing compliance-
induced flow irregularities in syringe pump infusion sys-
tems, particularly at lower flow rates. We could show in
the evaluated model using this syringe pump and in-line
filter combination that in-line filters represent an option to
optimize continuous administration of highly concen-
trated short-acting drugs at very small infusion rates.
In-line filters can be easily inserted and used with all
fluids except blood products and lipids. This study could
be the first step to evaluate a new measure to reduce
flow irregularities, but further work is required to vali-
date this approach for all different pump/syringe/filter
combinations.
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